PIK3CA Copy Number Aberration and Activation of the PI3K-AKT-mTOR Pathway in Varied Disease States of Penile Cancer

Overview

Journal PLoS One

Specialties General Medicine
Science

Date 2018 Jun 15

PMID 29902261

Authors

Anthony Adimonye

Elzbieta Stankiewicz

Susannah La-Touche

Sakunthala Kudahetti

Giorgia Trevisan

Brendan Tinwell

Cathy Corbishley

Yong-Jie Lu

Nick Watkin

Daniel Berney

Affiliations

Soon will be listed here.

Abstract

Background: Therapeutic targeting of the PI3K-AKT-mTOR pathway may benefit patients with advanced penile squamous cell carcinoma (PSCC).

Objectives: To determine the prevalence of PIK3CA copy number gain and correlate this with the activity status of PI3K-AKT-mTOR pathway in pre-malignant penile intraepithelial neoplasia (PeIN) and invasive PSCC.

Materials And Methods: Archival tissue blocks were obtained from 58 PeIN and 244 primary PSCC patients treated at St George's Hospital. PIK3CA copy number status (CNS) was assessed by fluorescence in-situ hybridisation. High-risk HPV DNA was detected with INNO-LiPA assay. p16INK4A, p-AKT and p-mTOR protein expression were assessed using immunohistochemistry (IHC).

Results: Increased prevalence of PIK3CA copy number gain was seen in PSCC in comparison to PeIN (84/199 (42%) vs. 10/58 (17%); p = 0.0009). Analysis of the p-AKT and p-mTOR revealed a tendency to a more common expression of cytoplasmic p-AKT (p = 0.1318), nuclear p-AKT (p<0.0001) and cytoplasmic mTOR (p = 0.0006) in PeIN than PSCC. A significant association between p-AKT cytoplasmic immunoexpression and PIK3CA CNS (p = 0.0404) was found in PeIN.

Conclusion: Overall, PIK3CA copy number gain correlated with activation of the PI3K-AKT-mTOR pathway in PeIN and activation of this pathway is primarily involved in early penile carcinogenesis. Based on these results therapeutic targeting of this pathway in advanced PSCC is unlikely to produce significant clinical benefit. Future studies will need to focus on alternative therapeutic targets.

References

Sonpavde G, Pagliaro L, Buonerba C, Dorff T, Lee R, Di Lorenzo G . Penile cancer: current therapy and future directions. Ann Oncol. 2013; 24(5):1179-89. PMC: 4047287. DOI: 10.1093/annonc/mds635. View

Stankiewicz E, Prowse D, Ng M, Cuzick J, Mesher D, Hiscock F . Alternative HER/PTEN/Akt pathway activation in HPV positive and negative penile carcinomas. PLoS One. 2011; 6(3):e17517. PMC: 3047574. DOI: 10.1371/journal.pone.0017517. View

Christodoulidou M, Sahdev V, Houssein S, Muneer A . Epidemiology of penile cancer. Curr Probl Cancer. 2015; 39(3):126-36. DOI: 10.1016/j.currproblcancer.2015.03.010. View

Ferrandiz-Pulido C, Masferrer E, de Torres I, Lloveras B, Hernandez-Losa J, Mojal S . Identification and genotyping of human papillomavirus in a Spanish cohort of penile squamous cell carcinomas: correlation with pathologic subtypes, p16(INK4a) expression, and prognosis. J Am Acad Dermatol. 2012; 68(1):73-82. DOI: 10.1016/j.jaad.2012.05.029. View

Rosner M, Freilinger A, Hengstschlager M . Akt regulates nuclear/cytoplasmic localization of tuberin. Oncogene. 2006; 26(4):521-31. DOI: 10.1038/sj.onc.1209812. View

Ali S, Pal S, Wang K, Palma N, Sanford E, Bailey M . Comprehensive Genomic Profiling of Advanced Penile Carcinoma Suggests a High Frequency of Clinically Relevant Genomic Alterations. Oncologist. 2015; 21(1):33-9. PMC: 4709208. DOI: 10.1634/theoncologist.2015-0241. View

Ferguson L, Chen H, Collins A, Connell M, Damia G, Dasgupta S . Genomic instability in human cancer: Molecular insights and opportunities for therapeutic attack and prevention through diet and nutrition. Semin Cancer Biol. 2015; 35 Suppl:S5-S24. PMC: 4600419. DOI: 10.1016/j.semcancer.2015.03.005. View

Heselmeyer K, Schrock E, Du Manoir S, Blegen H, Shah K, Steinbeck R . Gain of chromosome 3q defines the transition from severe dysplasia to invasive carcinoma of the uterine cervix. Proc Natl Acad Sci U S A. 1996; 93(1):479-84. PMC: 40262. DOI: 10.1073/pnas.93.1.479. View

Chaux A, Velazquez E, Algaba F, Ayala G, Cubilla A . Developments in the pathology of penile squamous cell carcinomas. Urology. 2010; 76(2 Suppl 1):S7-S14. DOI: 10.1016/j.urology.2010.02.038. View

10.

Ferrandiz-Pulido C, Masferrer E, Toll A, Hernandez-Losa J, Mojal S, Pujol R . mTOR signaling pathway in penile squamous cell carcinoma: pmTOR and peIF4E over expression correlate with aggressive tumor behavior. J Urol. 2013; 190(6):2288-95. DOI: 10.1016/j.juro.2013.06.015. View

11.

Thorpe L, Yuzugullu H, Zhao J . PI3K in cancer: divergent roles of isoforms, modes of activation and therapeutic targeting. Nat Rev Cancer. 2014; 15(1):7-24. PMC: 4384662. DOI: 10.1038/nrc3860. View

12.

Betz C, Hall M . Where is mTOR and what is it doing there?. J Cell Biol. 2014; 203(4):563-74. PMC: 3840941. DOI: 10.1083/jcb.201306041. View

13.

McDaniel A, Hovelson D, Cani A, Liu C, Zhai Y, Zhang Y . Genomic Profiling of Penile Squamous Cell Carcinoma Reveals New Opportunities for Targeted Therapy. Cancer Res. 2015; 75(24):5219-27. DOI: 10.1158/0008-5472.CAN-15-1004. View

14.

Pedrero J, Carracedo D, Pinto C, Zapatero A, Rodrigo J, Suarez Nieto C . Frequent genetic and biochemical alterations of the PI 3-K/AKT/PTEN pathway in head and neck squamous cell carcinoma. Int J Cancer. 2004; 114(2):242-8. DOI: 10.1002/ijc.20711. View

15.

Guimaraes G, Rocha R, Zequi S, Cunha I, Soares F . Penile cancer: epidemiology and treatment. Curr Oncol Rep. 2011; 13(3):231-9. DOI: 10.1007/s11912-011-0163-2. View

16.

Mannweiler S, Sygulla S, Winter E, Regauer S . Two major pathways of penile carcinogenesis: HPV-induced penile cancers overexpress p16ink4a, HPV-negative cancers associated with dermatoses express p53, but lack p16ink4a overexpression. J Am Acad Dermatol. 2013; 69(1):73-81. DOI: 10.1016/j.jaad.2012.12.973. View

17.

Murayama T, Inokuchi M, Takagi Y, Yamada H, Kojima K, Kumagai J . Relation between outcomes and localisation of p-mTOR expression in gastric cancer. Br J Cancer. 2009; 100(5):782-8. PMC: 2653759. DOI: 10.1038/sj.bjc.6604915. View

18.

Hakenberg O, Comperat E, Minhas S, Necchi A, Protzel C, Watkin N . EAU guidelines on penile cancer: 2014 update. Eur Urol. 2014; 67(1):142-150. DOI: 10.1016/j.eururo.2014.10.017. View

19.

Sakai N, Kajiyama Y, Iwanuma Y, Tomita N, Amano T, Isayama F . Study of abnormal chromosome regions in esophageal squamous cell carcinoma by comparative genomic hybridization: relationship of lymph node metastasis and distant metastasis to selected abnormal regions. Dis Esophagus. 2009; 23(5):415-21. DOI: 10.1111/j.1442-2050.2009.01026.x. View

20.

Rosner M, Hengstschlager M . Cytoplasmic and nuclear distribution of the protein complexes mTORC1 and mTORC2: rapamycin triggers dephosphorylation and delocalization of the mTORC2 components rictor and sin1. Hum Mol Genet. 2008; 17(19):2934-48. DOI: 10.1093/hmg/ddn192. View